AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SALBUTAMOL SULPHATE BP
7 registrations across 3 African markets— 3 active
Markets with SALBUTAMOL SULPHATE BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Salbutamol HFA inhaler Inhalation powder, pre-dispensed | 🇿🇲Zambia | Hetero Labs Limited | active | May 2031 |
| SALBODEX 100 Pressurized inhalation | 🇿🇲Zambia | Bliss GVS Pharma Ltd | active | Aug 2030 |
| SALBUT 4 TABLETS Tablet | 🇰🇪Kenya | COSMOS LIMITED | active | May 2029 |
| SALBRON 4MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| SALBUTAMOL 4MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| ASTHALIN 2MG/5ML SYRUP SYRUP | 🇲🇼Malawi | — | expired | Jun 2012 |
| ASMANOL 4MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2003 |
SALBUTAMOL SULPHATE BP in Africa — Regulatory Overview
SALBUTAMOL SULPHATE BP is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Zambia, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 3 (43%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.